APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical CRO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biopharmaceutical CRO Industry Growth and Trends Forecast to 2032

2 May 2026110 pages

Choose your research edition.

Industry ResearchBiopharmaceutical CRO Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical CRO Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical CRO Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical CRO Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

According to APO Research, the global Biopharmaceutical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biopharmaceutical CRO market include WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group and Fortrea, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biopharmaceutical CRO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biopharmaceutical CRO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biopharmaceutical CRO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biopharmaceutical CRO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biopharmaceutical CRO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biopharmaceutical CRO Market by Company

WuXi AppTec

WuXi Biologics

Hangzhou Tigermed

Pharmaron Beijing

ICON

PPD

BioPharma Services

TriStar Technology Group

Fortrea

Eurofins BioPharma Services

Medicilon

Asymchem

UBC

SanaClis

TFS HealthScience

Parexel

Biopharmaceutical CRO Segment by Type

Full-service CRO

Specialized CRO

Biopharmaceutical CRO Segment by Application

SMBs

Large Enterprises

Biopharmaceutical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biopharmaceutical CRO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceutical CRO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biopharmaceutical CRO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biopharmaceutical CRO Market Share by Region (2021-2026) Table 4. Global Biopharmaceutical CRO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biopharmaceutical CRO Market Share by Region (2027-2032) Table 6. Global Biopharmaceutical CRO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biopharmaceutical CRO Market Size Share by Type (2021-2026) Table 9. Global Biopharmaceutical CRO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biopharmaceutical CRO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biopharmaceutical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biopharmaceutical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biopharmaceutical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biopharmaceutical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biopharmaceutical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biopharmaceutical CRO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biopharmaceutical CRO Market Size Share by Application (2021-2026) Table 24. Global Biopharmaceutical CRO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biopharmaceutical CRO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biopharmaceutical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biopharmaceutical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biopharmaceutical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biopharmaceutical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biopharmaceutical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biopharmaceutical CRO Industry Trends Table 37. Biopharmaceutical CRO Industry Drivers Table 38. Biopharmaceutical CRO Industry Opportunities and Challenges Table 39. Biopharmaceutical CRO Industry Restraints Table 40. Global Biopharmaceutical CRO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biopharmaceutical CRO Revenue Market Share by Company (2021-2026) Table 42. Global Biopharmaceutical CRO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biopharmaceutical CRO Key Company Headquarters & Area Served Table 44. Global Biopharmaceutical CRO Company, Product Type & Application Table 45. Global Biopharmaceutical CRO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biopharmaceutical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. WuXi AppTec Company Information Table 49. WuXi AppTec Business Overview Table 50. WuXi AppTec Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. WuXi AppTec Biopharmaceutical CRO Product Portfolio Table 52. WuXi AppTec Recent Development Table 53. WuXi Biologics Company Information Table 54. WuXi Biologics Business Overview Table 55. WuXi Biologics Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. WuXi Biologics Biopharmaceutical CRO Product Portfolio Table 57. WuXi Biologics Recent Development Table 58. Hangzhou Tigermed Company Information Table 59. Hangzhou Tigermed Business Overview Table 60. Hangzhou Tigermed Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio Table 62. Hangzhou Tigermed Recent Development Table 63. Pharmaron Beijing Company Information Table 64. Pharmaron Beijing Business Overview Table 65. Pharmaron Beijing Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pharmaron Beijing Biopharmaceutical CRO Product Portfolio Table 67. Pharmaron Beijing Recent Development Table 68. ICON Company Information Table 69. ICON Business Overview Table 70. ICON Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. ICON Biopharmaceutical CRO Product Portfolio Table 72. ICON Recent Development Table 73. PPD Company Information Table 74. PPD Business Overview Table 75. PPD Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. PPD Biopharmaceutical CRO Product Portfolio Table 77. PPD Recent Development Table 78. BioPharma Services Company Information Table 79. BioPharma Services Business Overview Table 80. BioPharma Services Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. BioPharma Services Biopharmaceutical CRO Product Portfolio Table 82. BioPharma Services Recent Development Table 83. TriStar Technology Group Company Information Table 84. TriStar Technology Group Business Overview Table 85. TriStar Technology Group Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. TriStar Technology Group Biopharmaceutical CRO Product Portfolio Table 87. TriStar Technology Group Recent Development Table 88. Fortrea Company Information Table 89. Fortrea Business Overview Table 90. Fortrea Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Fortrea Biopharmaceutical CRO Product Portfolio Table 92. Fortrea Recent Development Table 93. Eurofins BioPharma Services Company Information Table 94. Eurofins BioPharma Services Business Overview Table 95. Eurofins BioPharma Services Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio Table 97. Eurofins BioPharma Services Recent Development Table 98. Medicilon Company Information Table 99. Medicilon Business Overview Table 100. Medicilon Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Medicilon Biopharmaceutical CRO Product Portfolio Table 102. Medicilon Recent Development Table 103. Asymchem Company Information Table 104. Asymchem Business Overview Table 105. Asymchem Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Asymchem Biopharmaceutical CRO Product Portfolio Table 107. Asymchem Recent Development Table 108. UBC Company Information Table 109. UBC Business Overview Table 110. UBC Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. UBC Biopharmaceutical CRO Product Portfolio Table 112. UBC Recent Development Table 113. SanaClis Company Information Table 114. SanaClis Business Overview Table 115. SanaClis Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. SanaClis Biopharmaceutical CRO Product Portfolio Table 117. SanaClis Recent Development Table 118. TFS HealthScience Company Information Table 119. TFS HealthScience Business Overview Table 120. TFS HealthScience Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. TFS HealthScience Biopharmaceutical CRO Product Portfolio Table 122. TFS HealthScience Recent Development Table 123. Parexel Company Information Table 124. Parexel Business Overview Table 125. Parexel Biopharmaceutical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Parexel Biopharmaceutical CRO Product Portfolio Table 127. Parexel Recent Development Table 128. North America Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Biopharmaceutical CRO Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Biopharmaceutical CRO Market Share by Country (2021-2026) Table 131. North America Biopharmaceutical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Biopharmaceutical CRO Market Share Forecast by Country (2027-2032) Table 133. Europe Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Biopharmaceutical CRO Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Biopharmaceutical CRO Market Share by Country (2021-2026) Table 136. Europe Biopharmaceutical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Biopharmaceutical CRO Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Biopharmaceutical CRO Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Biopharmaceutical CRO Market Share by Country (2021-2026) Table 141. Asia-Pacific Biopharmaceutical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Biopharmaceutical CRO Market Share Forecast by Country (2027-2032) Table 143. Latin America Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Biopharmaceutical CRO Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Biopharmaceutical CRO Market Share by Country (2021-2026) Table 146. Latin America Biopharmaceutical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Biopharmaceutical CRO Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Biopharmaceutical CRO Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Biopharmaceutical CRO Market Share by Country (2021-2026) Table 151. Middle East & Africa Biopharmaceutical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Biopharmaceutical CRO Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biopharmaceutical CRO Product Image Figure 3. Global Biopharmaceutical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 5. Global Biopharmaceutical CRO Market Share by Region: 2025 VS 2032 Figure 6. Global Biopharmaceutical CRO Market Share by Region (2021-2032) Figure 7. North America Biopharmaceutical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biopharmaceutical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biopharmaceutical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biopharmaceutical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biopharmaceutical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Full-service CRO Image Figure 13. Global Full-service CRO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Specialized CRO Image Figure 15. Global Specialized CRO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Biopharmaceutical CRO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Biopharmaceutical CRO Market Share by Type 2025 VS 2032 Figure 18. North America Biopharmaceutical CRO Market Size Share by Type (2021-2032) Figure 19. Europe Biopharmaceutical CRO Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Biopharmaceutical CRO Market Size Share by Type (2021-2032) Figure 21. Latin America Biopharmaceutical CRO Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Biopharmaceutical CRO Market Size Share by Type (2021-2032) Figure 23. SMBs Image Figure 24. Global SMBs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Large Enterprises Image Figure 26. Global Large Enterprises Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Biopharmaceutical CRO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Biopharmaceutical CRO Market Share by Application 2025 VS 2032 Figure 29. North America Biopharmaceutical CRO Market Size Share by Application (2021-2032) Figure 30. Europe Biopharmaceutical CRO Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Biopharmaceutical CRO Market Size Share by Application (2021-2032) Figure 32. Latin America Biopharmaceutical CRO Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Biopharmaceutical CRO Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Biopharmaceutical CRO Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Biopharmaceutical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Biopharmaceutical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 39. Europe Biopharmaceutical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Biopharmaceutical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 42. Asia-Pacific Biopharmaceutical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Biopharmaceutical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 45. Latin America Biopharmaceutical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Biopharmaceutical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 48. Middle East & Africa Biopharmaceutical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Biopharmaceutical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Full-service CRO
  • Specialized CRO
Applications
  • SMBs
  • Large Enterprises
Companies covered
  • WuXi AppTec
  • WuXi Biologics
  • Hangzhou Tigermed
  • Pharmaron Beijing
  • ICON
  • PPD
  • BioPharma Services
  • TriStar Technology Group
  • Fortrea
  • Eurofins BioPharma Services
  • Medicilon
  • Asymchem
  • UBC
  • SanaClis
  • TFS HealthScience
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biopharmaceutical CRO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biopharmaceutical CRO Market Size by Region (2021-2032)
  5. 1.4.1 Global Biopharmaceutical CRO Market Size by Region (2021-2026)
  6. 1.4.2 Global Biopharmaceutical CRO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biopharmaceutical CRO Market Size (2021-2032)
  8. 1.5.1 North America Biopharmaceutical CRO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biopharmaceutical CRO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biopharmaceutical CRO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biopharmaceutical CRO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biopharmaceutical CRO Market Size Growth Rate (2021-2032)
2 Biopharmaceutical CRO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Full-service CRO
  3. 2.1.2 Specialized CRO
  4. 2.2 Global Biopharmaceutical CRO Market Size by Type
  5. 2.2.1 Global Biopharmaceutical CRO Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Biopharmaceutical CRO Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Biopharmaceutical CRO Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Biopharmaceutical CRO Market Size by Regions
  9. 2.3.1 North America Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Biopharmaceutical CRO Market Size Breakdown by Type (2021-2026)
3 Biopharmaceutical CRO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 SMBs
  3. 3.1.2 Large Enterprises
  4. 3.2 Global Biopharmaceutical CRO Market Size by Application
  5. 3.2.1 Global Biopharmaceutical CRO Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Biopharmaceutical CRO Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Biopharmaceutical CRO Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Biopharmaceutical CRO Market Size by Regions
  9. 3.3.1 North America Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Biopharmaceutical CRO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biopharmaceutical CRO Industry Trends
  2. 4.2 Biopharmaceutical CRO Industry Drivers
  3. 4.3 Biopharmaceutical CRO Industry Opportunities and Challenges
  4. 4.4 Biopharmaceutical CRO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biopharmaceutical CRO Revenue (2021-2026)
  2. 5.2 Global Biopharmaceutical CRO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biopharmaceutical CRO Key Company Headquarters & Area Served
  4. 5.4 Global Biopharmaceutical CRO Company, Product Type & Application
  5. 5.5 Global Biopharmaceutical CRO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biopharmaceutical CRO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biopharmaceutical CRO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biopharmaceutical CRO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 WuXi AppTec
  2. 6.1.1 WuXi AppTec Company Information
  3. 6.1.2 WuXi AppTec Business Overview
  4. 6.1.3 WuXi AppTec Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 WuXi AppTec Biopharmaceutical CRO Product Portfolio
  6. 6.1.5 WuXi AppTec Recent Developments
  7. 6.2 WuXi Biologics
  8. 6.2.1 WuXi Biologics Company Information
  9. 6.2.2 WuXi Biologics Business Overview
  10. 6.2.3 WuXi Biologics Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 WuXi Biologics Biopharmaceutical CRO Product Portfolio
  12. 6.2.5 WuXi Biologics Recent Developments
  13. 6.3 Hangzhou Tigermed
  14. 6.3.1 Hangzhou Tigermed Company Information
  15. 6.3.2 Hangzhou Tigermed Business Overview
  16. 6.3.3 Hangzhou Tigermed Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio
  18. 6.3.5 Hangzhou Tigermed Recent Developments
  19. 6.4 Pharmaron Beijing
  20. 6.4.1 Pharmaron Beijing Company Information
  21. 6.4.2 Pharmaron Beijing Business Overview
  22. 6.4.3 Pharmaron Beijing Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pharmaron Beijing Biopharmaceutical CRO Product Portfolio
  24. 6.4.5 Pharmaron Beijing Recent Developments
  25. 6.5 ICON
  26. 6.5.1 ICON Company Information
  27. 6.5.2 ICON Business Overview
  28. 6.5.3 ICON Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 ICON Biopharmaceutical CRO Product Portfolio
  30. 6.5.5 ICON Recent Developments
  31. 6.6 PPD
  32. 6.6.1 PPD Company Information
  33. 6.6.2 PPD Business Overview
  34. 6.6.3 PPD Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 PPD Biopharmaceutical CRO Product Portfolio
  36. 6.6.5 PPD Recent Developments
  37. 6.7 BioPharma Services
  38. 6.7.1 BioPharma Services Company Information
  39. 6.7.2 BioPharma Services Business Overview
  40. 6.7.3 BioPharma Services Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 BioPharma Services Biopharmaceutical CRO Product Portfolio
  42. 6.7.5 BioPharma Services Recent Developments
  43. 6.8 TriStar Technology Group
  44. 6.8.1 TriStar Technology Group Company Information
  45. 6.8.2 TriStar Technology Group Business Overview
  46. 6.8.3 TriStar Technology Group Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 TriStar Technology Group Biopharmaceutical CRO Product Portfolio
  48. 6.8.5 TriStar Technology Group Recent Developments
  49. 6.9 Fortrea
  50. 6.9.1 Fortrea Company Information
  51. 6.9.2 Fortrea Business Overview
  52. 6.9.3 Fortrea Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Fortrea Biopharmaceutical CRO Product Portfolio
  54. 6.9.5 Fortrea Recent Developments
  55. 6.10 Eurofins BioPharma Services
  56. 6.10.1 Eurofins BioPharma Services Company Information
  57. 6.10.2 Eurofins BioPharma Services Business Overview
  58. 6.10.3 Eurofins BioPharma Services Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio
  60. 6.10.5 Eurofins BioPharma Services Recent Developments
  61. 6.11 Medicilon
  62. 6.11.1 Medicilon Company Information
  63. 6.11.2 Medicilon Business Overview
  64. 6.11.3 Medicilon Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Medicilon Biopharmaceutical CRO Product Portfolio
  66. 6.11.5 Medicilon Recent Developments
  67. 6.12 Asymchem
  68. 6.12.1 Asymchem Company Information
  69. 6.12.2 Asymchem Business Overview
  70. 6.12.3 Asymchem Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Asymchem Biopharmaceutical CRO Product Portfolio
  72. 6.12.5 Asymchem Recent Developments
  73. 6.13 UBC
  74. 6.13.1 UBC Company Information
  75. 6.13.2 UBC Business Overview
  76. 6.13.3 UBC Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 UBC Biopharmaceutical CRO Product Portfolio
  78. 6.13.5 UBC Recent Developments
  79. 6.14 SanaClis
  80. 6.14.1 SanaClis Company Information
  81. 6.14.2 SanaClis Business Overview
  82. 6.14.3 SanaClis Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 SanaClis Biopharmaceutical CRO Product Portfolio
  84. 6.14.5 SanaClis Recent Developments
  85. 6.15 TFS HealthScience
  86. 6.15.1 TFS HealthScience Company Information
  87. 6.15.2 TFS HealthScience Business Overview
  88. 6.15.3 TFS HealthScience Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 TFS HealthScience Biopharmaceutical CRO Product Portfolio
  90. 6.15.5 TFS HealthScience Recent Developments
  91. 6.16 Parexel
  92. 6.16.1 Parexel Company Information
  93. 6.16.2 Parexel Business Overview
  94. 6.16.3 Parexel Biopharmaceutical CRO Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Parexel Biopharmaceutical CRO Product Portfolio
  96. 6.16.5 Parexel Recent Developments
7 North America
  1. 7.1 North America Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biopharmaceutical CRO Market Size by Country (2021-2026)
  3. 7.3 North America Biopharmaceutical CRO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biopharmaceutical CRO Market Size by Country (2021-2026)
  3. 8.3 Europe Biopharmaceutical CRO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biopharmaceutical CRO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biopharmaceutical CRO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biopharmaceutical CRO Market Size by Country (2021-2026)
  3. 10.3 South America Biopharmaceutical CRO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biopharmaceutical CRO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biopharmaceutical CRO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst